Navigation Links
GenoSpace Founder and CEO Receives "Champions of Change" Award from White House

CAMBRIDGE, Mass., June 20, 2013 /PRNewswire/ -- The White House today recognized John Quackenbush, PhD, founder and Chief Executive Officer of GenoSpace, LLC, as an Open Science "Champion of Change". The program recognizes outstanding individuals, organizations and research projects promoting and using open scientific data and publications to accelerate progress and improve our world. GenoSpace builds information systems capable of storing and integrating genomic information and health data for clinical care and advanced research.  Kathy Giusti, founder and Chief Executive Officer of the Multiple Myeloma Research Foundation (MMRF), was also honored as an Open Science "Champion of Change".

(Logo: )

In 2011, the Multiple Myeloma Research Foundation (MMRF) launched the $40 million CoMMpass study, an open-science initiative that unites competitors from the pharmaceutical and biotech industries, academic institutions, and community cancer centers. The MMRF CoMMpass study will follow 1,000 patients for five years, monitoring their response to treatment and sequencing their cancer genomes to understand how they evolve under the selective pressure of drugs with which they are being treated. CoMMpass will provide unprecedented data that will be freely shared without restriction with anyone interested in using it to search for a cure.

In 2012, the MMRF turned to GenoSpace to solve the problem of making the data emerging from CoMMpass available, accessible, and useful to research community. GenoSpace for Research™, which enables the MMRF Researcher Gateway, is a revolutionary software system that integrates complex data and provides collaborating scientists with advanced analytical and visualization tools that drive discovery. The MMRF Researcher Gateway is currently open to the pharmaceutical sponsors of CoMMpass, and will be made available to the public in September of this year.

"We are very proud to have partnered with the MMRF and to be honored with them by the White House," said Quackenbush. "This award recognizes the groundbreaking work the team at GenoSpace has done in creating tools to support the next generation of genomic research and personalized medicine."

About GenoSpace
At GenoSpace, we are Digital Architects of Genomic Medicine™. GenoSpace is a Cambridge, Massachusetts-based company that has developed robust software systems for securely storing vast amounts of genomic and health data, and providing it in formats specific to its diverse user communities. GenoSpace for Clinical Care facilitates clinically actionable interpretation and report generation for precision medicine. GenoSpace for Research provides dynamic analysis, visualization and collaboration tools. GenoSpace for Patient Communities enables patient-centric exploration and advancement of personalized medicine. Please visit for more information.

GenoSpace Contact:
John Quackenbush
GenoSpace, LLC
700 Massachusetts Ave
Cambridge MA 02139
Phone: 617-520-4182

Copyright©2012 PR Newswire.
All rights reserved

Related biology technology :

1. GenoSpace Expands Its Management Team by Appointing Daniel Meyer as Chief Financial Officer
2. GenoSpace Announces the Launch of a Cloud-Based "Information Ecosystem" for Advancing 21st-Century Personalized Medicine
3. Founder, Prof. Stephen Chou to Give Tutorial on Nanoimprint at IEEE Nano 2013
4. Future of Pre- and Probiotics to be Discussed by Kibow Biotech Founder During SupplySide MarketPlace 2013 Global Expo & Conference
5. TREVENTIS Corporation Scientific Founder, Donald Weaver, MD, Named Sobey Chair in Alzheimers Disease Research, His Third Endowed Chair
6. Founder of National Childrens Leukemia Unveiled Non-Embryonic Stem Cell Treatment Promising Cure for Cancer at GIL 2012: Europe
7. Radiotherapy Clinics of Georgias Founder Returns Home to Celebrate Cancer Survivors and Receive Lifetime Achievement Award
8. Telome Health Co-founder and Nobel Laureate Elizabeth Blackburn Awarded Innovator of the Year
9. Express Diagnostics’ DrugCheck® On-site Test Cup Receives Health Canada Class III Medical Device Approval
10. AMRI Burlington Receives DEA Approval to Handle Controlled Substances
11. zuChem Receives Two Polyol Patents
Post Your Comments:
(Date:10/8/2015)... 2015 Global Biologics and ... and Biosimilars industry . --> Big ... Biosimilars Industry 2015 Deep Market Research Report, Size, ... professional and depth research report on Global ... ) , --> ) , ...
(Date:10/8/2015)... /PRNewswire/ - RepliCel Life Sciences Inc. (OTCQB: REPCF) (TSX.V: RP), ... development of autologous cell therapies, today announced its schedule of ... in the month of October: Stem Cell ... will be presenting at the annual Partnering Forum, part ... be held October 7-9 in La Jolla, ...
(Date:10/8/2015)... ... October 08, 2015 , ... ... an exclusive license agreement to develop and commercialize intellectual property rights belonging to ... agreement from February 2009, and affords exclusive worldwide rights to intellectual property based ...
(Date:10/7/2015)... ... October 07, 2015 , ... Neil Riordan, PhD to Discuss Medicinal ... October 8th, at Mar-a-Lago from 3:50 pm to 4:30 pm. , Dr. Riordan is ... , He is the Co-Founder and Chief Science Officer of the ...
Breaking Biology Technology:
... Mach One Corporation (Pink Sheets: MNCN), a global ... long term benefit to the agricultural and consumer markets, ... of Modular Process Constructors LLC (MPC).Mach One acquired 100% ... Series B convertible preferred stock at a conversion price ...
... Accuray Incorporated,(Nasdaq: ARAY ), a ... today,that 10 percent of its U.S. installed base ... service. Treatment planning by medical physicists,is a core ... , Accuray,s treatment planning ...
... 20 Elsevier announced today,that Scopus(R), its ... (A&C) database, was chosen by the Australian ... for Australia (ERA) initiative. , ... research quality within Australia,s higher,education institutions using ...
Cached Biology Technology:
(Date:10/6/2015)... 2015  Maverix Biomics, Inc., a leading genomic ... software portfolio with the debut of its RNA-Seq ... in eukaryotes. The software is integrated into the ... analysis solution that leverages proven open-source algorithms and ... efforts. Garry Nolan,s laboratory at ...
(Date:10/2/2015)... -- ) has announced ... Using Biometrics" report to their offering. ... of the "Enforcing the Law Using Biometrics" ... Research and Markets ( ) has announced ... Using Biometrics" report to their offering. ...
(Date:9/30/2015)... Calif. , Sept. 30, 2015  With nearly ... the number of new SCIs estimated to reach 12,500 ... Southern California Resource Services for Independent Living ... ILCs in California opening doors ... range of programs and services, notably assistive technology services ...
Breaking Biology News(10 mins):
... the University of Iowa and Brigham Young University (BYU) ... for overcoming drug resistance in cancer. The finding could ... cancer and monitoring patients, response to treatment but also ... cancer cells. Drug resistance is a common problem ...
... new open access publishing program that offers immediate publication ... process, executed after publication. Following recent approval by the ... that pass this peer review process will now be ... F1000Research ,s acceptance by the NLM ...
... register now for the American College of Medical Genetics ... 2013 at the Phoenix Convention Center. From Genetic Testing ... Meeting is on the actual practice of genetics and ... conference will showcase the latest breakthroughs in genetics research ...
Cached Biology News:
... MW: 60kDa (A) and 36kDa (C) ... pH 7.5, 500mM NaCl, 60mM 2-mercaptoethanol, ... 1mM DTT, and 0.1mg/ml serum albumin ... of proteins. Purification: DEAE chromatography, aminohexyl-agarose ...
... Intracellular Localization Kit provides a straight forward ... of your design, in an efficient yet ... Subcellular localization and functional inhibition of target ... of the labeled siRNA into mammalian cells. ...
... IT siRNA Tracker Intracellular Localization Kit ... straight forward approach to directly label ... in an efficient yet non-destructive manner, ... localization and functional inhibition of target ...
... This kit allows for quick and reproducible ... plate. The system is more reproducible than regular ... the protein A/G agarose without disrupting the agarose ... Catch and Release is reversible, and elution of ...
Biology Products: